ClinicalTrials.govpublic full text
First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2)
her2-positive gastric cancer, metastatic gastric cancer, unresectable gastric carcinoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 868406
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.